학술논문
PB2038: LENALIDOMIDE OR BORTEZOMIB AS MAINTENANCE TREATMENT OVERCOMES INFERIOR IMPACT OF HIGH-RISK CYTOGENETIC ABNORMALITIES IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA IN CHINA
Document Type
article
Author
Source
HemaSphere, Vol 6, Pp 1909-1910 (2022)
Subject
Language
English
ISSN
2572-9241